Sample | Title | Value | Rank |
GSM958322 | U87-EV human glioblastoma xenograft - Control - 1 [HG-U133_Plus_2] | 13.1262 | 99 |
GSM958323 | U87-EV human glioblastoma xenograft - Control - 2 [HG-U133_Plus_2] | 12.9621 | 99 |
GSM958324 | U87-EV human glioblastoma xenograft - Control - 3 [HG-U133_Plus_2] | 12.9358 | 99 |
GSM958328 | U87-EV human glioblastoma xenograft - Bevacizumab treated - 1 [HG-U133_Plus_2] | 13.0766 | 99 |
GSM958329 | U87-EV human glioblastoma xenograft - Bevacizumab treated - 2 [HG-U133_Plus_2] | 13.1744 | 99 |
GSM958330 | U87-EV human glioblastoma xenograft - Bevacizumab treated - 3 [HG-U133_Plus_2] | 13.0726 | 99 |
GSM958325 | U87-EV human glioblastoma xenograft - dibenzazepine treated - 1 [HG-U133_Plus_2] | 13.1409 | 99 |
GSM958326 | U87-EV human glioblastoma xenograft - dibenzazepine treated - 2 [HG-U133_Plus_2] | 13.1152 | 99 |
GSM958327 | U87-EV human glioblastoma xenograft - dibenzazepine treated - 3 [HG-U133_Plus_2] | 13.0675 | 99 |